Advanced Respiratory and Sleep Medicine
Huntersville, North Carolina, United States
Sleep clinic in Huntersville, North Carolina
16507 Northcross Dr suite f, Huntersville, NC 28078
About Advanced Respiratory and Sleep Medicine
"Advanced Respiratory and Sleep Medicine, PLLC offers state of the art sleep and pulmonary services in Huntersville NC. Our physicians are board certified in multiple disciplines, including critical care, pediatrics, pulmonary medicine, preventive medicine and sleep medicine. Not only do we strive to provide top-notch care, we also work hard to provide a stress-free and innovative healthcare experience for our patients."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Advanced Respiratory and Sleep Medicine
During the past decade, Advanced Respiratory and Sleep Medicine conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
2008-10-16
2029-09-20
Recruiting
720
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
2010-07-31
2016-09-16
Completed
1,095
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
2012-09-03
2016-04-30
Terminated
415
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)
2013-04-03
2025-04-03
Active, not recruiting
1,487
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
2014-01-31
2021-06-04
Completed
1,846
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Advanced Respiratory and Sleep Medicine" #1 sponsor was "Jazz Pharmaceuticals" with 3 trials, followed by "Bleep, LLC" with 2 trials
sponsored, "Harmony Biosciences, LLC" with 2 trials sponsored, "NLS Pharmaceutics" with 2 trials sponsored and "Avadel"
with 2 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Respiratory and Sleep Medicine"
#1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Advanced Respiratory and Sleep Medicine
According to Clinical.Site data, the most researched conditions in "Advanced Respiratory and Sleep Medicine" are
"Narcolepsy" (5 trials), "Obstructive Sleep Apnea" (4 trials), "Excessive Daytime Sleepiness" (2 trials), "Idiopathic Hypersomnia" (2 trials) and "Cataplexy" (1 trials). Many other conditions were trialed in "Advanced Respiratory and Sleep Medicine" in a lesser frequency.
Clinical Trials Intervention Types at Advanced Respiratory and Sleep Medicine
Most popular intervention types in "Advanced Respiratory and Sleep Medicine" are "Drug" (9 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "JZP-110" (3 trials), "Placebo oral tablet" (3 trials), "Eclipse novel CPAP mask" (2 trials), "Phillips Respironics Nuance" (2 trials) and "FT218" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Advanced Respiratory and Sleep Medicine
The vast majority of trials in "Advanced Respiratory and Sleep Medicine" are
11 trials for "All" genders.
Clinical Trials Status at Advanced Respiratory and Sleep Medicine
Currently, there are NaN active trials in "Advanced Respiratory and Sleep Medicine".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 8 completed trials in Advanced Respiratory and Sleep Medicine,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Advanced Respiratory and Sleep Medicine, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".